Mary Chapman, features writer —

Supernus Pharmaceuticals’ acquisition of US WorldMeds’ portfolio of central nervous system (CNS) disease treatments adds two established Parkinson’s disease (PD) therapies and a leading investigative product to its neurology portfolio. The deal calls for a $300 million upfront cash outlay, plus $230 million in milestone payments for…

Parkinson Voice Project has given a second grant to the Speech-Language Institute (SLI) at Salus University, enabling it to continue its SPEAK OUT! & LOUD Crowd therapy programs. Through the grant — the amount was not specified — the SLI will continue offering free group speech therapy to Parkinson’s patients…

Accure Therapeutics announced its opening, supported by €7.6 million (about $8.1 million) in Series A funding. The Barcelona, Spain-based pharmaceutical company will focus on developing treatment candidates for central nervous system (CNS) disorders such as Parkinson’s disease. The funding round was led by Alta Life Sciences, and…

The Michael J. Fox Foundation (MJFF) is offering a new online Parkinson’s disease educational series aimed at researchers and clinicians. Parkinson’s Disease Therapeutics Webinars, a free four-part series, starts June 16 and will feature presentations by leaders in Parkinson’s research and treatment development. “We know people with…

With numerous clinical trials interrupted due to the COVID-19 pandemic, The Michael J. Fox Foundation (MJFF) is highlighting online ways that Parkinson’s (PD) patients and others can help to advance research. People are necessarily spending more time at home, but study participation remains crucial to treatment development. Even before…

The Parkinson’s Foundation and the U.S. Department of Veterans Affairs (VA) are collaborating on an effort to improve the health and life quality of veterans with Parkinson’s disease. The two want to provide people who served in the U.S. Armed Forces with better resources and ways to manage Parkinson’s, a…

To help patients and their families cope with the global COVID-19 outbreak, The Michael J. Fox Foundation (MJFF) is launching a limited-series podcast. The series begins today, May 6, and is part of MJFF’s ongoing Parkinson’s Podcast. It’s available every other Wednesday on michaeljfox.org/podcasts, Google…

Throughout the global COVID-19 pandemic, the Invertigo Dance Theatre will conduct its weekly Dancing Through Parkinson’s (DTP) classes online. Starting May 7, the Los Angeles, California-based company will offer free streaming classes live on Zoom each Thursday at 1:30 p.m. PST. The sessions will be recorded and available…

To support the global Parkinson’s disease community during the COVID-19 pandemic, The Michael J. Fox Foundation (MJFF) is spotlighting its new information and resource hub. The dedicated site includes webinars, podcasts, online educational events, insights and tips regarding PD and the coronavirus, and a virtual…

Nitrome Biosciences has raised $38 million in Series A financing to advance its lead program toward clinical trials for Parkinson’s disease (PD) and other age-related disorders. “This financing will enable Nitrome to advance our mission of impacting the lives of patients with neurodegenerative and other age-related diseases,” said…